Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 395Neoplasms 338Prostatic Neoplasms 189Lung Neoplasms 176Colorectal Neoplasms 143Motor Activity 88Uterine Cervical Neoplasms 75Pancreatic Neoplasms 74Head and Neck Neoplasms 70Brain Neoplasms 69Carcinoma, Non-Small-Cell Lung 64Ovarian Neoplasms 60Carcinoma, Hepatocellular 51Rectal Neoplasms 49Colonic Neoplasms 46Glioblastoma 42Anxiety Disorders 41Precursor Cell Lymphoblastic Leukemia-Lymphoma 40Neoplasm Metastasis 40Depression 39Hematologic Neoplasms 38Glioma 36Melanoma 35Stomach Neoplasms 33Multiple Myeloma 33Disease 33Sarcoma 31Carcinoma, Renal Cell 31Urinary Bladder Neoplasms 30Pain 28

Interventions

Magnetic Resonance Spectroscopy 1Lymph Node Excision 1Indocyanine Green 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Mixed Tumor, Mesodermal × 90 days × Clear all
NCT01737619 2026-05-04

PET/CT and Lymph Node Mapping in Finding Lymph Node Metastasis in Patients With High-Risk Endometrial Cancer

M.D. Anderson Cancer Center

Phase NA Active not recruiting
101 enrolled 8 charts

Mixed Tumor, Mesodermal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡